Breaking

Medication

2 stories

AllUNIQUEPHARMACEUTICALNOVONORDISKELILILLYAMGENFDAMERCKHEALTHPHARMACEUTICALSTGMCENVIRONMENT CANADAAKSTONPHARMACYTELANGANA DCAIMHDEAMHRAAMBLEPLASTICSURGERYAKSTON BIOSCIENCESTLCFFXNOWLIPFENDRAHSCPREP4ALLMEDSCAPEGSKFRACTYLHEALTHTRUMPRXTELEHEALTHGLENMARKMEDICAREEUROPEAN COMMISSIONHMSACVSCAR EMARKONCOLOGYKETABONPHARMACEUTICALLUPINLEQEMBIASCENSIONSAHPRAKENVUE
Clinical chart comparing eight FDA-approved CGRP-targeted agents for migraine treatment.
MEDSCAPE3d ago

Deep Dive: CGRP Therapies: First-Line Status, New Safety Signal

The landscape for migraine treatment changed significantly as of March 2024. The American Headache Society updated its position statement to designate CGRP-targeted therapies as a first-line option for migraine preventio

Dr. Caroline Messer, an endocrinologist, during a professional medical presentation.
5d ago

My Mother Had Alzheimer’s. That’s Why I Started a GLP-1 at 48

← BACK TO ALL HEALTH NEWS